Metabolome-Defined Obesity and the Risk of Future Type 2 Diabetes and Mortality.
Filip OttossonEinar SmithUlrika EricsonLouise BrunkwallMarju Orho-MelanderSalvatore Di SommaPaola AntoniniPeter M NilssonCéline FernandezOlle MelanderPublished in: Diabetes care (2022)
We found that lean individuals with an obesity-related metabolome have an increased risk for type 2 diabetes and all-cause mortality compared with lean individuals with a healthy metabolome. Metabolomics may be used to identify hidden high-risk individuals to initiate lifestyle and pharmacological interventions.